{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T19:41:58Z","timestamp":1648928518925},"reference-count":39,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Med Report"],"DOI":"10.3892\/mmr.2017.7892","type":"journal-article","created":{"date-parts":[[2017,10,26]],"date-time":"2017-10-26T07:55:15Z","timestamp":1509004515000},"source":"Crossref","is-referenced-by-count":2,"title":["Anticancer effect of quinacrine on diffuse large B\u2011cell lymphoma via inhibition of MSI2\u2011NUMB signaling pathway"],"prefix":"10.3892","author":[{"given":"Shujun","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Hematology, Ningbo First Hospital, Ningbo, Zhejiang 315010, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lixia","family":"Sheng","sequence":"additional","affiliation":[{"name":"Department of Hematology, Ningbo First Hospital, Ningbo, Zhejiang 315010, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaihong","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Ningbo First Hospital, Ningbo, Zhejiang 315010, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Ningbo First Hospital, Ningbo, Zhejiang 315010, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiling","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Ningbo First Hospital, Ningbo, Zhejiang 315010, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Ningbo First Hospital, Ningbo, Zhejiang 315010, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qitian","family":"Mu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Ningbo First Hospital, Ningbo, Zhejiang 315010, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guifang","family":"Ouyang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Ningbo First Hospital, Ningbo, Zhejiang 315010, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2017,10,26]]},"reference":[{"key":"key20200713223037_b1-mmr-17-01-0522","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1182\/blood-2010-03-276246","article-title":"Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: A study by the Groupe d'Etudes des Lymphomes de l'Adulte","volume":"116","author":"Coiffier","year":"2010","journal-title":"Blood"},{"key":"key20200713223037_b2-mmr-17-01-0522","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1182\/asheducation-2011.1.498","article-title":"Relapsed\/refractory diffuse large B-cell lymphoma","volume":"2011","author":"Friedberg","year":"2011","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"key20200713223037_b3-mmr-17-01-0522","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1478-811X-9-13","article-title":"Beyond DNA binding-a review of the potential mechanisms mediating quinacrine's therapeutic activities in parasitic infections, inflammation, and cancers","volume":"9","author":"Ehsanian","year":"2011","journal-title":"Cell Commun Signal"},{"key":"key20200713223037_b4-mmr-17-01-0522","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1002\/ijc.26158","article-title":"Quinacrine has anticancer activity in breast cancer cells through inhibition of topoisomerase activity","volume":"130","author":"Preet","year":"2012","journal-title":"Int J Cancer"},{"key":"key20200713223037_b5-mmr-17-01-0522","doi-asserted-by":"publisher","first-page":"893","DOI":"10.4161\/cbt.4.8.2134","article-title":"Acridine derivatives activate p53 and induce tumor cell death through Bax","volume":"4","author":"Wang","year":"2005","journal-title":"Cancer Biol Ther"},{"key":"key20200713223037_b6-mmr-17-01-0522","doi-asserted-by":"publisher","first-page":"239","DOI":"10.4161\/cbt.12.3.17034","article-title":"Quinacrine synergizes with 5-fluorouracil and other therapies in colorectal cancer","volume":"12","author":"Gallant","year":"2011","journal-title":"Cancer Biol Ther"},{"key":"key20200713223037_b7-mmr-17-01-0522","doi-asserted-by":"publisher","first-page":"19162","DOI":"10.1074\/jbc.M109.091645","article-title":"Inhibition of NF-kappaB signaling by quinacrine is cytotoxic to human colon carcinoma cell lines and is synergistic in combination with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) or oxaliplatin","volume":"285","author":"Jani","year":"2010","journal-title":"J Biol Chem"},{"key":"key20200713223037_b8-mmr-17-01-0522","doi-asserted-by":"publisher","first-page":"6568","DOI":"10.1158\/1078-0432.CCR-07-1591","article-title":"Deficient TP53 expression, function, and cisplatin sensitivity are restored by quinacrine in head and neck cancer","volume":"13","author":"Friedman","year":"2007","journal-title":"Clin Cancer Res"},{"key":"key20200713223037_b9-mmr-17-01-0522","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1159\/000313525","article-title":"Quinacrine enhances cisplatin-induced cytotoxicity in four cancer cell lines","volume":"56","author":"Wang","year":"2010","journal-title":"Chemotherapy"},{"key":"key20200713223037_b10-mmr-17-01-0522","doi-asserted-by":"publisher","first-page":"229","DOI":"10.4161\/cbt.12.3.17033","article-title":"Quinacrine sensitizes hepatocellular carcinoma cells to TRAIL and chemotherapeutic agents","volume":"12","author":"Wang","year":"2011","journal-title":"Cancer Biol Ther"},{"key":"key20200713223037_b11-mmr-17-01-0522","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.curtheres.2012.02.003","article-title":"Quinacrine inhibits cell growth and induces apoptosis in human gastric cancer cell line SGC-7901","volume":"73","author":"Wu","year":"2012","journal-title":"Curr Ther Res Clin Exp"},{"key":"key20200713223037_b12-mmr-17-01-0522","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1084\/jem.20130736","article-title":"Musashi-2 controls cell fate, lineage bias, and TGF-\u03b2 signaling in HSCs","volume":"211","author":"Park","year":"2014","journal-title":"J Exp Med"},{"key":"key20200713223037_b13-mmr-17-01-0522","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0896-6273(00)80279-2","article-title":"Asymmetric localization of a mammalian numb homolog during mouse cortical neurogenesis","volume":"17","author":"Zhong","year":"1996","journal-title":"Neuron"},{"key":"key20200713223037_b14-mmr-17-01-0522","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0896-6273(00)80278-0","article-title":"Control of daughter cell fates during asymmetric division: Interaction of Numb and Notch","volume":"17","author":"Guo","year":"1996","journal-title":"Neuron"},{"key":"key20200713223037_b15-mmr-17-01-0522","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/hep.27923","article-title":"Alternative splicing of the cell fate determinant Numb in hepatocellular carcinoma","volume":"62","author":"Lu","year":"2015","journal-title":"Hepatology"},{"key":"key20200713223037_b16-mmr-17-01-0522","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.2217\/fon.09.127","article-title":"New hopes from old drugs: Revisiting DNA-binding small molecules as anticancer agents","volume":"5","author":"Gurova","year":"2009","journal-title":"Future Oncol"},{"key":"key20200713223037_b17-mmr-17-01-0522","doi-asserted-by":"publisher","first-page":"3960","DOI":"10.4161\/cc.8.23.10179","article-title":"Anti-malaria drug blocks proteotoxic stress response: Anti-cancer implications","volume":"8","author":"Neznanov","year":"2009","journal-title":"Cell Cycle"},{"key":"key20200713223037_b18-mmr-17-01-0522","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1038\/onc.2008.460","article-title":"9-Aminoacridine-based anticancer drugs target the PI3K\/AKT\/mTOR, NF-kappaB and p53 pathways","volume":"28","author":"Guo","year":"2009","journal-title":"Oncogene"},{"key":"key20200713223037_b19-mmr-17-01-0522","doi-asserted-by":"publisher","first-page":"17448","DOI":"10.1073\/pnas.0508888102","article-title":"Small molecules that reactivate p53 in renal cell carcinoma reveal a NF-kappaB-dependent mechanism of p53 suppression in tumors","volume":"102","author":"Gurova","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20200713223037_b20-mmr-17-01-0522","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3727\/096504012X13473664562628","article-title":"Quinacrine-mediated autophagy and apoptosis in colon cancer cells is through a p53- and p21-dependent mechanism","volume":"20","author":"Mohapatra","year":"2012","journal-title":"Oncol Res"},{"key":"key20200713223037_b21-mmr-17-01-0522","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1093\/carcin\/bgs351","article-title":"Lycopene synergistically enhances quinacrine action to inhibit Wnt-TCF signaling in breast cancer cells through APC","volume":"34","author":"Preet","year":"2013","journal-title":"Carcinogenesis"},{"key":"key20200713223037_b22-mmr-17-01-0522","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1158\/1535-7163.MCT-14-0013","article-title":"Quinacrine overcomes resistance to erlotinib by inhibiting FACT, NF-\u03baB, and cell-cycle progression in non-small cell lung cancer","volume":"13","author":"Dermawan","year":"2014","journal-title":"Mol Cancer Ther"},{"key":"key20200713223037_b23-mmr-17-01-0522","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.taap.2015.02.005","article-title":"Quinacrine induces apoptosis in human leukemia K562 cells via p38 MAPK-elicited BCL2 down-regulation and suppression of ERK\/c-Jun-mediated BCL2L1 expression","volume":"284","author":"Changchien","year":"2015","journal-title":"Toxicol Appl Pharmacol"},{"key":"key20200713223037_b24-mmr-17-01-0522","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.bcp.2016.01.017","article-title":"Chk1 inhibitor synergizes quinacrine mediated apoptosis in breast cancer cells by compromising the base excision repair cascade","volume":"105","author":"Preet","year":"2016","journal-title":"Biochem Pharmacol"},{"key":"key20200713223037_b25-mmr-17-01-0522","first-page":"1202","article-title":"A novel gene, MSI2, encoding a putative RNA-binding protein is recurrently rearranged at disease progression of chronic myeloid leukemia and forms a fusion gene with HOXA9 as a result of the cryptic t(7;17)(p15;q23)","volume":"63","author":"Barbouti","year":"2003","journal-title":"Cancer Res"},{"key":"key20200713223037_b26-mmr-17-01-0522","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1083\/jcb.200708004","article-title":"Neural RNA-binding protein Musashi1 inhibits translation initiation by competing with eIF4G for PABP","volume":"181","author":"Kawahara","year":"2008","journal-title":"J Cell Biol"},{"key":"key20200713223037_b27-mmr-17-01-0522","doi-asserted-by":"publisher","first-page":"3888","DOI":"10.1128\/MCB.21.12.3888-3900.2001","article-title":"The neural RNA-binding protein Musashi1 translationally regulates mammalian numb gene expression by interacting with its mRNA","volume":"21","author":"Imai","year":"2001","journal-title":"Mol Cell Biol"},{"key":"key20200713223037_b28-mmr-17-01-0522","first-page":"639","article-title":"The progression of gliomas is associated with cancer stem cell phenotype","volume":"19","author":"Kong","year":"2008","journal-title":"Oncol Rep"},{"key":"key20200713223037_b29-mmr-17-01-0522","doi-asserted-by":"publisher","first-page":"8402","DOI":"10.1073\/pnas.0600906103","article-title":"The RNA-binding protein Musashi is required intrinsically to maintain stem cell identity","volume":"103","author":"Siddall","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20200713223037_b30-mmr-17-01-0522","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.1128\/MCB.00040-08","article-title":"Musashi1 modulates mammary progenitor cell expansion through proliferin-mediated activation of the Wnt and Notch pathways","volume":"28","author":"Wang","year":"2008","journal-title":"Mol Cell Biol"},{"key":"key20200713223037_b31-mmr-17-01-0522","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1053\/j.gastro.2008.02.057","article-title":"Knockdown of RNA binding protein musashi-1 leads to tumor regression in vivo","volume":"134","author":"Sureban","year":"2008","journal-title":"Gastroenterology"},{"key":"key20200713223037_b32-mmr-17-01-0522","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.leukres.2013.05.012","article-title":"High expression of Musashi-2 indicates poor prognosis in adult B-cell acute lymphoblastic leukemia","volume":"37","author":"Mu","year":"2013","journal-title":"Leuk Res"},{"key":"key20200713223037_b33-mmr-17-01-0522","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/ijlh.12284","article-title":"Prognostic significance of MSI2 predicts unfavorable outcome in adult B-acute lymphoblastic leukemia","volume":"37","author":"Aly","year":"2015","journal-title":"Int J Lab Hematol"},{"key":"key20200713223037_b34-mmr-17-01-0522","doi-asserted-by":"crossref","first-page":"14359","DOI":"10.18632\/oncotarget.8736","article-title":"Musashi2 promotes the development and progression of pancreatic cancer by down-regulating Numb protein","volume":"8","author":"Sheng","year":"2017","journal-title":"Oncotarget"},{"key":"key20200713223037_b35-mmr-17-01-0522","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0065-230X(07)99004-1","article-title":"The c-myc promoter: Still MysterY and challenge","volume":"99","author":"Wierstra","year":"2008","journal-title":"Adv Cancer Res"},{"key":"key20200713223037_b36-mmr-17-01-0522","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.3324\/haematol.2013.086173","article-title":"MYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell lymphoma treated with immunochemotherapy","volume":"98","author":"Valera","year":"2013","journal-title":"Haematologica"},{"key":"key20200713223037_b37-mmr-17-01-0522","doi-asserted-by":"publisher","first-page":"e0136484","DOI":"10.1371\/journal.pone.0136484","article-title":"Musashi-2 silencing exerts potent activity against acute myeloid leukemia and enhances chemosensitivity to daunorubicin","volume":"10","author":"Han","year":"2015","journal-title":"PLoS One"},{"key":"key20200713223037_b38-mmr-17-01-0522","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1007\/s13277-014-2918-5","article-title":"Overexpression of Numb suppresses growth, migration, and invasion of human clear cell renal cell carcinoma cells","volume":"36","author":"Sima","year":"2015","journal-title":"Tumour Biol"},{"key":"key20200713223037_b39-mmr-17-01-0522","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.1128\/MCB.8.8.3080","article-title":"c-myc can induce expression of G0\/G1 transition genes","volume":"8","author":"Schweinfest","year":"1988","journal-title":"Mol Cell Biol"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T21:43:06Z","timestamp":1594676586000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mmr.2017.7892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,26]]},"references-count":39,"URL":"https:\/\/doi.org\/10.3892\/mmr.2017.7892","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,26]]}}}